Next Generation Medicine: Specialty Drug Costs, Data & Supply Chain
Specialty drugs accounted for an estimated 40%-50% of drug spend in 2020. An influx of new gene therapies has an expected sales forecast of $16 billion in 2024.
At the same time, clinical advancements have allowed for the creation of cures and treatments for a number of chronic illnesses and previously untreatable diseases.
Watch the panel discussion from The Council’s Employee Benefits Leadership Forum, which examines contracting strategies, plan design and personalized medicine.
Featuring:
Chris Crawford, Chief Growth Officer, Vivio Health
Joshua Fredell, PharmD, Vice President, Product Development, CVS Health
Laura Jester, Senior Director, Specialty/Pharmacy Solutions, Navitus Health Solutions
Scott Musial, Chief Pharmacy Officer, Rightway Healthcare
Moderated by: Ryan Rice, Principal & Practice Leader, Prism Health Strategists




